Dr. Manash Biswas
Director - Gynaecologic Oncology
Cancer Care / Oncology, Gynecologic Oncology
Share Doctor Profile
Select Hospital
About Dr. Manash Biswas
- 14 years of experience as Gynaecologic Oncologist in the Armed Forces Medical Services
- Experience in the Cancer Care Team of Quaternary Care Hospitals of the Armed Forces Medical Services – Army Hospital Research & Referral Delhi, AFMC & Command Hospital Pune and Command Hospital (AF) Bangalore
- Professor & Head at Dept of Obstetrics & Gynaecology, Armed Forces Medical College, Pune
- Associate Director Gynae Onco Surgery at Max Institute of Cancer Care, Max Super Speciality Hospital, Saket, New Delhi, since July 2019
- Currently, Vice President of ‘Association of Gynaecologic Oncologists of India’
- MBBS, Armed Forces Medical College, Pune
- MD (Gynaecology), Armed Forces Medical College, Pune
- Fellowship (Gynae Oncology), FICRS VC, Mayo Clinic, Rochester, USA
- Fellowship Gynaecologic Oncology, Tata Memorial Hospital, Mumbai, 2003
- Visiting Clinician, Division of GynOnco Surgery, Mayo Clinic, Rochester, 2010
- Gynae Onco Minimal Access Workshop at Indo American Hospital, Hyderabad,2013
- International Course Workshop on CRS & HIPEC, TMH Mumbai
- FICRS, Fellowship Training in Robotic Surgery, WLH, Gurgaon
- Association of Gynaecologic Oncologists of India (AGOI) (Life Member)
- International Gynecologic Cancer Society (IGCS)
- Indian Society of Peritoneal Surface Malignancies (Life Member)
- Indian Society of Colposcopy & Cervical Pathology (ISCCP) (Life Member)
- Delhi Oncology Forum (Life Member)
- Association of Obstetricians and Gynaecologists of Delhi (AOGD)
- Federation of Obstetric & Gynaecological Societies of India (FOGSI)
- Awarded the Chief of Air Staff’s Commendation Medal in 2013
- Aggressive Cytoreductive Surgery & HIPEC in Ovarian Cancer
- Minimal Access Surgery in Gynae Onco (Laparoscopic & Robotic)
- Surgery in Vaginal Vulvar Cancer
- Specialist in Robotic Surgery & HIPEC
- Referee and Reviewer of publications – MJAFI & IJGO
- Original work - Neoadjuvant Chemotherapy in Cancer Cervix - A Phase 2 trial
- Risk of Malignancy Index to evaluate adnexal masses for purpose of referring patients to Gyanecologic Oncology centers of Armed Forces
- Correlation of HPV DNA Hybridization study using hybrid capture 2 technology with video Colposcopy and PAP smear in cases of cervical dysplasia
- 26 articles including 5 chapters in books. Articles are in peer – reviewed International (01) and National Journals (21)
OPD Timings
Max Super Speciality Hospital, Saket
- Tue : 9:00 AM - 11:00 AM